Abstract
Prenatal cannabis exposure (PCE) is associated with mental health problems in early adolescence, but the possible neurobiological mechanisms remain unknown. In a large longitudinal sample of adolescents (ages 9–12 years, n = 9,322–10,186), we find that PCE is associated with localized differences in gray and white matter of the frontal and parietal cortices, their associated white matter tracts, and striatal resting-state connectivity, even after accounting for potential pregnancy, familial, and child confounds. Variability in forceps minor and pars triangularis diffusion metrics partially longitudinally mediate associations of PCE with attention problems and attention deficit hyperactivity disorder symptoms. PCE-related differences in brain development may confer vulnerability to worse mental health in early adolescence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$79.00 per year
only $6.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development (ABCD) Study (https://abcdstudy.org), held in the NIMH Data Archive (NDA). This is a multisite, longitudinal study designed to recruit more than 10,000 children aged 9–10 and follow them over 10 years into early adulthood. The ABCD data repository grows and changes over time. The ABCD data used in this report came from https://doi.org/10.15154/8873-zj65. DOIs can be found at https://nda.nih.gov/abcd/abcd-annual-releases.html. The dataset identifier is https://doi.org/10.15154/dxx6-fk12. Cannabis use disorder summary statistics are available for download at https://pgc.unc.edu/for-researchers/download-results/. Additional datasets used for processing genetic data are available at https://sites.google.com/a/broadinstitute.org/ricopili.
Code availability
Analysis code is available at https://github.com/WashU-BG/PCE_MRI.
References
Volkow, N. D., Han, B., Compton, W. M. & McCance-Katz, E. F. Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA 322, 167–169 (2019).
What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding (FDA, 2020); https://www.fda.gov/consumers/consumer-updates/what-you-should-know-about-using-cannabis-including-cbd-when-pregnant-or-breastfeeding
Office of the Surgeon General US Surgeon General’s Advisory: Marijuana Use and the Developing Brain (HHS, 2019); https://www.hhs.gov/surgeongeneral/reports-and-publications/addiction-and-substance-misuse/advisory-on-marijuana-use-and-developing-brain/index.html
Marijuana and Pregnancy (American College of Obstetricians and Gynecologists, 2023); https://www.acog.org/womens-health/infographics/marijuana-and-pregnancy
Sorkhou, M., Singla, D. R., Castle, D. J. & George, T. P. Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: a systematic review and meta‐analysis. Addiction https://doi.org/10.1111/add.16370 (2023).
Olyaei, A. F., Campbell, L. R., Roberts, V. H. J. & Lo, J. O. Animal models evaluating the impact of prenatal exposure to tobacco and marijuana. Clin. Obstet. Gynecol. 65, 334–346 (2022).
Day, N. L., Goldschmidt, L., Day, R., Larkby, C. & Richardson, G. A. Prenatal marijuana exposure, age of marijuana initiation, and the development of psychotic symptoms in young adults. Psychol. Med. 45, 1779–1787 (2015).
Goldschmidt, L., Day, N. L. & Richardson, G. A. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol. Teratol. 22, 325–336 (2000).
Gray, K. A., Day, N. L., Leech, S. & Richardson, G. A. Prenatal marijuana exposure: effect on child depressive symptoms at ten years of age. Neurotoxicol. Teratol. 27, 439–448 (2005).
Power, E. et al. Intelligence quotient decline following frequent or dependent cannabis use in youth: a systematic review and meta-analysis of longitudinal studies. Psychol. Med. 51, 194–200 (2021).
Huizink, A. C. Prenatal cannabis exposure and infant outcomes: overview of studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 52, 45–52 (2014).
Ruisch, I. H., Dietrich, A., Glennon, J. C., Buitelaar, J. K. & Hoekstra, P. J. Maternal substance use during pregnancy and offspring conduct problems: a meta-analysis. Neurosci. Biobehav. Rev. 84, 325–336 (2018).
Zammit, S. et al. Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring. Br. J. Psychiatry 195, 294–300 (2009).
Dong, C. et al. Cannabinoid exposure during pregnancy and its impact on immune function. Cell. Mol. Life Sci. 76, 729–743 (2019).
Rokeby, A. C. E., Natale, B. V. & Natale, D. R. C. Cannabinoids and the placenta: receptors, signaling and outcomes. Placenta 135, 51–61 (2023).
Vacher, C.-M. et al. Placental endocrine function shapes cerebellar development and social behavior. Nat. Neurosci. 24, 1392–1401 (2021).
Bonnin, A. et al. A transient placental source of serotonin for the fetal forebrain. Nature 472, 347–350 (2011).
Ursini, G. et al. Prioritization of potential causative genes for schizophrenia in placenta. Nat. Commun. 14, 2613 (2023).
Lu, H.-C. & Mackie, K. Review of the endocannabinoid system. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 6, 607–615 (2021).
Scheyer, A. F., Melis, M., Trezza, V. & Manzoni, O. J. J. Consequences of perinatal cannabis exposure. Trends Neurosci. 42, 871–884 (2019).
Higuera-Matas, A., Ucha, M. & Ambrosio, E. Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes. Neurosci. Biobehav. Rev. 55, 119–146 (2015).
Navarro, M. & Rubio, P. Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology 122, 1–14 (1995).
Lo, J. O., Hedges, J. C. & Metz, T. D. Cannabis use and perinatal health research. JAMA https://doi.org/10.1001/jama.2023.14697 (2023).
Paul, S. E. et al. Associations between prenatal cannabis exposure and childhood outcomes: results from the ABCD Study. JAMA Psychiatry 78, 64–76 (2021).
Faraj, M. M. et al. Impact of prenatal cannabis exposure on functional connectivity of the salience network in children. J. Neurosci. Res. 101, 162–171 (2023).
El Marroun, H. et al. Prenatal cannabis and tobacco exposure in relation to brain morphology: a prospective neuroimaging study in young children. Biol. Psychiatry 79, 971–979 (2016).
Peterson, B. S. et al. Associations of maternal prenatal drug abuse with measures of newborn brain structure, tissue organization, and metabolite concentrations. JAMA Pediatr. 174, 831–842 (2020).
Evanski, J. M. et al. The first ‘hit’ to the endocannabinoid system? Associations between prenatal cannabis exposure and frontolimbic white matter pathways in children. Biol. Psychiatry Glob. Open Sci. 4, 11–18 (2024).
Vishnubhotla, R. V., Ahmad, S. T., Zhao, Y. & Radhakrishnan, R. Impact of prenatal marijuana exposure on adolescent brain structural and functional connectivity and behavioral outcomes. Brain Commun. https://doi.org/10.1093/braincomms/fcae001 (2024).
Casey, B. J. et al. The Adolescent Brain Cognitive Development (ABCD) Study: imaging acquisition across 21 sites. Dev. Cogn. Neurosci. 32, 43–54 (2018).
Zurolo, E. et al. CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies. Neuroscience 170, 28–41 (2010).
Buckley, N. E., Hansson, S., Harta, G. & Mezey, É. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 82, 1131–1149 (1997).
Wu, C.-S., Jew, C. P. & Lu, H.-C. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol. 6, 459–480 (2011).
Johnson, E. C. et al. A large-scale genome-wide association study meta-analysis of cannabis use disorder. Lancet Psychiatry 7, 1032–1045 (2020).
Baranger, D. A. A. et al. Association of mental health burden with prenatal cannabis exposure from childhood to early adolescence: longitudinal findings from the Adolescent Brain Cognitive Development (ABCD) Study. JAMA Pediatr. 176, 1261–1265 (2022).
Fine, J. D. et al. Association of prenatal cannabis exposure with psychosis proneness among children in the Adolescent Brain Cognitive Development (ABCD) Study. JAMA Psychiatry 76, 762–764 (2019).
Jacobus, J. et al. Adolescent cortical thickness pre- and post marijuana and alcohol initiation. Neurotoxicol. Teratol. 57, 20–29 (2016).
Robinson, E. A. et al. Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: a systematic review of diffusion-weighted MRI studies. Front. Neuroimaging 2, 1129587 (2023).
Navarri, X. et al. How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings. Hum. Brain Mapp. 43, 399–413 (2022).
Lorenzetti, V., Gaillard, A., Thomson, D., Englund, A. & Freeman, T. P. Effects of cannabinoids on resting state functional brain connectivity: a systematic review. Neurosci. Biobehav. Rev. 145, 105014 (2023).
Elman, J. A. et al. Genetic and environmental influences on cortical mean diffusivity. NeuroImage 146, 90–99 (2017).
Kim, E. et al. Mapping acute neuroinflammation in vivo with diffusion-MRI in rats given a systemic lipopolysaccharide challenge. Brain. Behav. Immun. 113, 289–301 (2023).
Roberts, V. H. J. et al. Chronic prenatal delta-9-tetrahydrocannabinol exposure adversely impacts placental function and development in a rhesus macaque model. Sci. Rep. 12, 20260 (2022).
Rompala, G., Nomura, Y. & Hurd, Y. L. Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring. Proc. Natl Acad. Sci. USA 118, e2106115118 (2021).
Walter, L. & Stella, N. Cannabinoids and neuroinflammation. Br. J. Pharmacol. 141, 775–785 (2004).
Palmer, C. E. et al. Microstructural development from 9 to 14 years: evidence from the ABCD Study. Dev. Cogn. Neurosci. 53, 101044 (2022).
Meier, M. H. et al. Preparedness for healthy ageing and polysubstance use in long-term cannabis users: a population-representative longitudinal study. Lancet Healthy Longev. 3, e703–e714 (2022).
Allen, J. P. et al. Lifetime marijuana use and epigenetic age acceleration: a 17-year prospective examination. Drug Alcohol Depend. 233, 109363 (2022).
Marek, S. et al. Reproducible brain-wide association studies require thousands of individuals. Nature 603, 654–660 (2022).
van Ewijk, H., Heslenfeld, D. J., Zwiers, M. P., Buitelaar, J. K. & Oosterlaan, J. Diffusion tensor imaging in attention deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 36, 1093–1106 (2012).
Hoogman, M. et al. Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples. Am. J. Psychiatry 176, 531–542 (2019).
Ruiz-Rizzo, A. L. et al. Subjective cognitive decline predicts lower cingulo-opercular network functional connectivity in individuals with lower neurite density in the forceps minor. Neuroimage 263, 119662 (2022).
Badre, D. & Wagner, A. D. Left ventrolateral prefrontal cortex and the cognitive control of memory. Neuropsychologia 45, 2883–2901 (2007).
de Zeeuw, P. & Durston, S. in The Wiley Handbook of Cognitive Control (ed. Egner, T.) 602–618 (John Wiley & Sons, 2017); https://doi.org/10.1002/9781118920497.ch33
Zheng, S. et al. Measurement bias in caregiver-report of early childhood behavior problems across demographic factors in an ECHO-wide diverse sample. JCPP Adv. 4, e12198 (2024).
De Los Reyes, A. et al. The validity of the multi-informant approach to assessing child and adolescent mental health. Psychol. Bull. 141, 858–900 (2015).
Karver, M. S. Determinants of multiple informant agreement on child and adolescent behavior. J. Abnorm. Child Psychol. 34, 251–262 (2006).
Tingley, D., Yamamoto, T., Hirose, K., Keele, L. & Imai, K. mediation: R package for causal mediation analysis. J. Stat. Softw. https://doi.org/10.18637/jss.v059.i05 (2014).
D’Onofrio, B. M. et al. Smoking during pregnancy and offspring externalizing problems: an exploration of genetic and environmental confounds. Dev. Psychopathol. 20, 139–164 (2008).
Hagler, D. J. et al. Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. Neuroimage 202, 116091 (2019).
Xue, F. Multi-Modal Processing Stream. NeuroImaging Tools & Resources Collaboratory https://www.nitrc.org/frs/?group_id=1256&release_id=3948 (2018).
Fischl, B. FreeSurfer. Neuroimage 62, 774–781 (2012).
Dosenbach, N. U. F. et al. Real-time motion analytics during brain MRI improve data quality and reduce costs. Neuroimage 161, 80–93 (2017).
Kennedy, J. T. et al. Reliability and stability challenges in ABCD task fMRI data. Neuroimage 252, 119046 (2022).
Achenbach, T, M. & Rescorla, L. A. Manual for the ASEBA School-Age Forms & Profiles: An Integrated System of Multi-Informant Assessment (Univ. Vermont, Research Center for Children, Youth, & Families, 2001).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (American Psychiatric Association, 2013).
Thompson, P. M. et al. ENIGMA and global neuroscience: a decade of large-scale studies of the brain in health and disease across more than 40 countries. Transl. Psychiatry 10, 100 (2020).
Karcher, N. R. et al. Assessment of the prodromal questionnaire–brief child version for measurement of self-reported psychoticlike experiences in childhood. JAMA Psychiatry 75, 853–861 (2018).
Petersen, A. C., Crockett, L., Richards, M. & Boxer, A. A self-report measure of pubertal status: reliability, validity, and initial norms. J. Youth Adolesc. 17, 117–133 (1988).
Lam, M. et al. RICOPILI: Rapid Imputation for Consortias PipeLIne. Bioinformatics 36, 930–933 (2020).
Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
Ge, T., Chen, C.-Y., Ni, Y., Feng, Y.-C. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2021).
Bates, D. et al. Fitting linear mixed-effects models using lme4. J. Stat. Softw. https://doi.org/10.18637/jss.v067.i01 (2015).
Varoquaux, G. Cross-validation failure: small sample sizes lead to large error bars. Neuroimage 180, 68–77 (2017).
Acknowledgements
This study was supported by R01DA54750 (R.B., A.A.). Additional funding included the following: D.A.A.B. (K99AA030808), A.P.M. (T32DA015035), A.J.G. (DGE-213989), S.E.P. (F31AA029934), A.S.H. (K01AA030083), E.C.J. (K01DA051759; BBRF Young Investigator Grant 29571), C.E.R. (R01DA046224), A.A. (R01DA54750), and R.B. (R01DA54750, R21AA027827, U01DA055367). Data for this study were provided by the Adolescent Brain Cognitive Development (ABCD) Study, which was funded by awards U01DA041022, U01DA041025, U01DA041028, U01DA041048, U01DA041089, U01DA041093, U01DA041106, U01DA041117, U01DA041120, U01DA041134, U01DA041148, U01DA041156, U01DA041174, U24DA041123 and U24DA041147 from the NIH and additional federal partners (https://abcdstudy.org/federal-partners.html). We thank T. Sheahan for her assistance with figure graphics. The ABCD Study is supported by the National Institutes of Health and additional federal partners under award numbers U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041123 and U24DA041147. A full list of supporters is available at https://abcdstudy.org/federal-partners.html. A listing of participating sites and a complete listing of the study investigators can be found at https://abcdstudy.org/consortium_members/. ABCD consortium investigators designed and implemented the study and/or provided data but did not necessarily participate in the analysis or writing of this report. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD consortium investigators.
Author information
Authors and Affiliations
Contributions
D.A.A.B. performed statistical analyses and prepared figures and tables. D.A.A.B. and R.B. drafted the paper. D.A.A.B., S.E.P., A.S.H., A.A., and R.B. designed the study. S.M.C.C. and E.C.J. computed polygenic scores and performed quality assurance checks of genetic data. A.A. and R.B. obtained funding. All authors, including A.J.G., A.P.M., C.D.S., C.E.R. and J.D.B. revised the paper and provided critical intellectual contributions.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Mental Health thanks Wayne Hall, Hilary Marusak and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Figs. 1 and 2.
Supplementary Tables
Supplementary Tables 1–5.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Baranger, D.A.A., Miller, A.P., Gorelik, A.J. et al. Prenatal cannabis exposure, the brain, and psychopathology during early adolescence. Nat. Mental Health 2, 975–986 (2024). https://doi.org/10.1038/s44220-024-00281-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44220-024-00281-7